Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.47 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.43 |
| ▸ | TGM2 | P21980 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | LSS | P48449 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7857937 | 0.88 | TAAR1 (0.41) | TAAR1HTR2APYCR1GPR52TGM2 | |
| SCHEMBL9004469 | 0.87 | GFER (0.36) | — | |
| SCHEMBL8062755 | 0.86 | TAAR1 (0.46) | TAAR1HTR2APYCR1GPR52TGM2 | |
| SCHEMBL6285109 | 0.85 | GFER (0.41) | — | |
| SCHEMBL8073311 | 0.85 | TAAR1 (0.45) | TAAR1HTR2APYCR1GPR52TGM2 | |
| SCHEMBL6141697 | 0.84 | TAAR1 (0.37) | TAAR1HTR2APYCR1GPR52TGM2 | |
| SCHEMBL7859007 | 0.84 | TAAR1 (0.37) | TAAR1HTR2APYCR1GPR52TGM2 | |
| SCHEMBL15065059 | 0.83 | USP2 (0.44) | TAAR1HTR2APYCR1GPR52 | |
| SCHEMBL8078219 | 0.83 | USP2 (0.44) | TAAR1HTR2APYCR1GPR52 | |
| SCHEMBL8072998 | 0.83 | USP2 (0.44) | TAAR1HTR2APYCR1GPR52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113372489-B | Temperature-sensitive delayed water shutoff agent and preparation method and application thereof | 山东诺尔生物科技有限公司 | 2021-10-29 | — | — | CN | claimed |
| CN-113372489-A | Temperature-sensitive delayed water shutoff agent and preparation method and application thereof | 山东诺尔生物科技有限公司 | 2021-09-10 | — | — | CN | claimed |
| EP-2173740-A1 | HEME-OXYGENASE INHIBITORS AND USE OF THE SAME IN THE TREATMENT OF CANCER AND DISEASES OF THE CENTRAL NERVOUS SYSTEM | Osta Biotechnologies (CA) | 2010-04-14 | — | — | EP | claimed |
| WO-2008151437-A1 | HEME-OXYGENASE INHIBITORS AND USE OF THE SAME IN THE TREATMENT OF CANCER AND DISEASES OF THE CENTRAL NERVOUS SYSTEM | OSTA BIOTECHNOLOGIES (CA) | 2008-12-18 | — | — | WO | claimed |
| EP-4504742-B1 | SILICONE-SOLUBLE ACYLPHOSPHINE OXIDE PHOTOINITIATOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-05-20 | — | — | EP | disclosed |
| US-20260116904-A1 | SILOXANE FUNCTIONALIZED PLATINUM OXALATE COMPLEX | DOW SILICONES CORP (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4709733-A1 | SILOXANE FUNCTIONALIZED PLATINUM OXALATE COMPLEX | Dow Silicones Corporation (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20250215160-A1 | ACYLPHOSPHINE OXIDE PHOTOINITIATOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-03 | — | — | US | disclosed |
| US-20250206889-A1 | SILICONE-SOLUBLE ACYLPHOSPHINE OXIDE PHOTOINITIATOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-06-26 | — | — | US | disclosed |
| WO-2025064221-A1 | PHOTOCURABLE ORGANOPOLYSILOXANE RESIN | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-03-27 | — | — | WO | disclosed |
| WO-2025064220-A1 | PHOTOCURABLE ORGANOPOLYSILOXANE RESIN | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-03-27 | — | — | WO | disclosed |
| EP-4504741-A1 | ACYLPHOSPHINE OXIDE PHOTOINITIATOR | Dow Global Technologies LLC (US) | 2025-02-12 | — | — | EP | disclosed |
| EP-0466183-B1 | Cyclosiloxanes with mesogenic side groups | CONSORTIUM ELEKTROCHEM IND (DE) | 1995-09-20 | — | — | EP | disclosed |
| EP-0637580-A1 | Process for preparing 1-bromoalkylbenzene derivatives and intermediates thereof | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1995-02-08 | — | — | EP | disclosed |
| EP-0424959-B1 | Organosilylalkyl-aromatic compounds | CONSORTIUM ELEKTROCHEM IND (DE) | 1995-02-01 | — | — | EP | disclosed |
| US-5304667-A | Cyclosiloxanes containing mesogenic side groups | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1994-04-19 | — | — | US | disclosed |
| US-5221759-A | CYCLOSILOXANES CONTAINING MESOGENIC SIDE GROUPS | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1993-06-22 | — | — | US | disclosed |
| US-5210247-A | ORGANOSILYLALKYLAROMATIC COMPOUNDS | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1993-05-11 | — | — | US | disclosed |
| EP-0466183-A1 | Cyclosiloxanes with mesogenic side groups | Consortium für elektrochemische Industrie GmbH (DE) | 1992-01-15 | — | — | EP | disclosed |
| EP-0424959-A2 | Organosilylalkyl-aromatic compounds | Consortium für elektrochemische Industrie GmbH (DE) | 1991-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250206889-A1 | SILICONE-SOLUBLE ACYLPHOSPHINE OXIDE PHOTOINITIATOR | MSR1, PIGS, F12 | TAAR1 1032/4885HTR2A 3296/4885PYCR1 2293/4885 |
| US-20250215160-A1 | ACYLPHOSPHINE OXIDE PHOTOINITIATOR | ARSA, H1-3, MPST | TAAR1 2133/4885HTR2A 3023/4885PYCR1 2427/4885 |
| US-20260116904-A1 | SILOXANE FUNCTIONALIZED PLATINUM OXALATE COMPLEX | CCRL2, ORC3, OXGR1 | TAAR1 1296/4885HTR2A 4020/4885PYCR1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.